Fesoterodine Fumarate
These highlights do not include all the information needed to use FESOTERODINE FUMARATE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for FESOTERODINE FUMARATE EXTENDED-RELEASE TABLETS. FESOTERODINE FUMARATE extended-release tablets, for oral use Initial U.S. Approval: 2008
b1abd9cb-c480-437b-8531-e2de3e188363
HUMAN PRESCRIPTION DRUG LABEL
Jun 10, 2022
Ascend Laboratories, LLC
DUNS: 141250469
Products 2
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Fesoterodine Fumarate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (10)
Fesoterodine Fumarate
Product Details
FDA regulatory identification and product classification information